Document is current
Any future updates will be listed below
-
Authors
Novello, Silvia
Terzolo, Massimo
Paola, Berchialla https://orcid.org/0000-0001-5835-5638
Gianetta, Martina
Bianco, Valentina
Arizio, Francesca
Brero, Dalila
Perini, Anna Maria Elena
Boccuzzi, Adriana
Caramello, Valeria
Perboni, Alberto
Bellavia, Fabio
Scagliotti, Giorgio Vittorio
- License Information
-
More Information
Article History
Received: 17 September 2021
Accepted: 13 December 2021
First Online: 30 December 2021
Competing interests
: GVS received honoraria from AstraZeneca, Eli Lilly, MSD, Pfizer, Roche, Johnson & Johnson, Takeda; consulting or advisory role for Eli Lilly, Beigene and Astrazeneca, received institutional research funding from Eli Lilly and MSD and received travel, accommodations from Bayer, all unrelated to the present study. SN received honoraria or consulted for Eli Lilly, Amgen, Beigene, AstraZeneca, Bristol Myers Squibb, Abbvie, Boehringer Ingelheim, MSD, Roche, Pfizer and Takeda, all unrelated to the present study. MT received honoraria and research funding from HRA PHARMA Rare Diseaseas and advisory role for Corcept Therapeutics, all unrelated to the present study.
